Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-10

FDA Approved: LILETTA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LILETTA (levonorgestrel) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LILETTA (LEVONORGESTREL)

Snippet

SUPPL AP for LILETTA (LEVONORGESTREL)